These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826 [TBL] [Abstract][Full Text] [Related]
23. The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process. Binato R; de Almeida Oliveira NC; Du Rocher B; Abdelhay E Cancer Lett; 2015 Dec; 369(1):134-43. PubMed ID: 26279521 [TBL] [Abstract][Full Text] [Related]
24. AML1/RUNX1 gene point mutations in childhood myeloid malignancies. Migas A; Savva N; Mishkova O; Aleinikova OV Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243 [TBL] [Abstract][Full Text] [Related]
25. [Pathobiology of acute myeloid leukemia]. Christ O; Feuring-Buske M; Hiddemann W; Buske C Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932 [TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. Bereshchenko O; Mancini E; Moore S; Bilbao D; Månsson R; Luc S; Grover A; Jacobsen SE; Bryder D; Nerlov C Cancer Cell; 2009 Nov; 16(5):390-400. PubMed ID: 19878871 [TBL] [Abstract][Full Text] [Related]
27. New strategies for relapsed acute myeloid leukemia: fertile ground for translational research. Dinner SN; Giles FJ; Altman JK Curr Opin Hematol; 2014 Mar; 21(2):79-86. PubMed ID: 24419335 [TBL] [Abstract][Full Text] [Related]
29. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908 [TBL] [Abstract][Full Text] [Related]
30. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies]. Goyama S Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629 [TBL] [Abstract][Full Text] [Related]
31. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome. Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131 [TBL] [Abstract][Full Text] [Related]
32. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment? Muntean AG; Hess JL Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728 [TBL] [Abstract][Full Text] [Related]
33. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Larson RA; Le Beau MM Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816 [TBL] [Abstract][Full Text] [Related]
34. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia. Newcombe AA; Gibson BES; Keeshan K Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923 [TBL] [Abstract][Full Text] [Related]
35. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656 [TBL] [Abstract][Full Text] [Related]
36. FLT3 mutations in a 10 year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns. Andersson A; Paulsson K; Lilljebjörn H; Lassen C; Strömbeck B; Heldrup J; Behrendtz M; Johansson B; Fioretos T Genes Chromosomes Cancer; 2008 Jan; 47(1):64-70. PubMed ID: 17943971 [TBL] [Abstract][Full Text] [Related]
37. Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells. Petrov I; Suntsova M; Mutorova O; Sorokin M; Garazha A; Ilnitskaya E; Spirin P; Larin S; Kovalchuk O; Prassolov V; Zhavoronkov A; Roumiantsev A; Buzdin A Aging (Albany NY); 2016 Nov; 8(11):2936-2947. PubMed ID: 27870639 [TBL] [Abstract][Full Text] [Related]
38. The role of mutations in the cohesin complex in acute myeloid leukemia. Mazumdar C; Majeti R Int J Hematol; 2017 Jan; 105(1):31-36. PubMed ID: 27796738 [TBL] [Abstract][Full Text] [Related]